Chi‐Ho Lee
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
-
- Thyroid Disorders and Treatments
- Diabetes Treatment and Management
Papers in
-
- Diabetes Treatment and Management 22
- Thyroid Disorders and Treatments 15
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
-
- COVID-19 Clinical Research Studies 23
- Co-authors
- Yu Cho WooYugyung LeeDavid Tak Wai LuiJin‐Wook YooKaren S.L. LamKathryn Choon Beng TanCarol Ho-Yan FongWing Chow
- Journals
- The Journal of Clinical Endocrinology & Metabolism (14 papers)Journal of Diabetes Investigation (7 papers)International Journal of Pharmaceutics (7 papers)Cardiovascular Diabetology (7 papers)Frontiers in Endocrinology (7 papers)
- Partner nations
- Hong KongChinaSouth Korea
In The Last Decade
Chi‐Ho Lee
297 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 174
- Pharmaceutical Science 406
- Endocrinology, Diabetes and Metabolism 1.0k
- Rehabilitation 291
- Physiology 999
- Infectious Diseases 528
Countries citing papers authored by Chi‐Ho Lee
This map shows the geographic impact of Chi‐Ho Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Ho Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Ho Lee more than expected).
Fields of papers citing papers by Chi‐Ho Lee
This network shows the impact of papers produced by Chi‐Ho Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Ho Lee. The network helps show where Chi‐Ho Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chi‐Ho Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 22 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 16 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 16 | |
| 15 | 2021 | 35 | |
| 16 | 2021 | 44 | |
| 17 | 2020 | 2 | |
| 18 | 2020 | 20 | |
| 19 | Biophoton emission and blood flow in the Human Hand | 2018 | 0 |
| 20 | 2008 | 58 |
About Chi‐Ho Lee
Chi‐Ho Lee is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases, Nephrology, Epidemiology and Pharmaceutical Science, having authored 316 papers that have together received 6.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (23 papers), Diabetes Treatment and Management (22 papers), Liver Disease Diagnosis and Treatment (22 papers), Metabolism, Diabetes, and Cancer (18 papers), Thyroid Disorders and Treatments (15 papers), Adipokines, Inflammation, and Metabolic Diseases (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Diabetes and associated disorders (11 papers). The work is most often cited by research in Pharmaceutical Science (406 citations), Endocrinology, Diabetes and Metabolism (1.0k citations), Rehabilitation (291 citations), Physiology (999 citations) and Infectious Diseases (528 citations). Chi‐Ho Lee has collaborated with scholars based in Hong Kong, China and South Korea. Frequent co-authors include Yu Cho Woo, Yugyung Lee, David Tak Wai Lui, Jin‐Wook Yoo, Karen S.L. Lam, Kathryn Choon Beng Tan, Carol Ho-Yan Fong, Wing Chow, Karen Siu Ling Lam and William J. Dieckmann. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Diabetes Investigation, International Journal of Pharmaceutics, Cardiovascular Diabetology and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.